Identification and Validation of the Pyroptosis-Related Molecular Subtypes of Lung Adenocarcinoma by Bioinformatics and Machine Learning

被引:40
作者
Liu, Le-Ping [1 ]
Lu, Lu [1 ]
Zhao, Qiang-Qiang [1 ]
Kou, Qin-Jie [2 ]
Jiang, Zhen-Zhen [1 ]
Gui, Rong [1 ]
Luo, Yan-Wei [1 ]
Zhao, Qin-Yu [1 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp 3, Dept Blood Transfus, Changsha, Peoples R China
[2] Cent South Univ, Xiangya Hosp 3, Dept Lab Med, Changsha, Peoples R China
[3] Australian Natl Univ, Coll Engn & Comp Sci, Canberra, ACT, Australia
基金
中国国家自然科学基金;
关键词
lung adenocarcinoma; pyroptosis; subtype; machine learning; prognostic; CANCER; RNA; INFLAMMASOME; BIOMARKERS; SIGNATURE; GENE;
D O I
10.3389/fcell.2021.756340
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Lung cancer remains the leading cause of cancer death globally, with lung adenocarcinoma (LUAD) being its most prevalent subtype. Due to the heterogeneity of LUAD, patients given the same treatment regimen may have different responses and clinical outcomes. Therefore, identifying new subtypes of LUAD is important for predicting prognosis and providing personalized treatment for patients. Pyroptosis-related genes play an essential role in anticancer, but there is limited research investigating pyroptosis in LUAD. In this study, 33 pyroptosis gene expression profiles and clinical information were collected from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. By bioinformatics and machine learning analyses, we identified novel subtypes of LUAD based on 10 pyroptosis-related genes and further validated them in the GEO dataset, with machine learning models performing up to an AUC of 1 for classifying in GEO. A web-based tool was established for clinicians to use our clustering model (). LUAD patients were clustered into 3 subtypes (A, B, and C), and survival analysis showed that B had the best survival outcome and C had the worst survival outcome. The relationships between pyroptosis gene expression and clinical characteristics were further analyzed in the three molecular subtypes. Immune profiling revealed significant differences in immune cell infiltration among the three molecular subtypes. GO enrichment and KEGG pathway analyses were performed based on the differential genes of the three subtypes, indicating that differentially expressed genes (DEGs) were involved in multiple cellular and biological functions, including RNA catabolic process, mRNA catabolic process, and pathways of neurodegeneration-multiple diseases. Finally, we developed an 8-gene prognostic model that accurately predicted 1-, 3-, and 5-year overall survival. In conclusion, pyroptosis-related genes may play a critical role in LUAD, and provide new insights into the underlying mechanisms of LUAD.
引用
收藏
页数:14
相关论文
共 53 条
[1]  
[Anonymous], 2018, CA Cancer J Clin, DOI DOI 10.3322/caac.20115
[2]   Glioma-Associated Stromal Cells Stimulate Glioma Malignancy by Regulating the Tumor Immune Microenvironment [J].
Cai, Xiangming ;
Yuan, Feng ;
Zhu, Junhao ;
Yang, Jin ;
Tang, Chao ;
Cong, Zixiang ;
Ma, Chiyuan .
FRONTIERS IN ONCOLOGY, 2021, 11
[3]   Analysis of Autophagy-Related Signatures Identified Two Distinct Subtypes for Evaluating the Tumor Immune Microenvironment and Predicting Prognosis in Ovarian Cancer [J].
Chen, Xingyu ;
Lan, Hua ;
He, Dong ;
Wang, Zhanwang ;
Xu, Runshi ;
Yuan, Jing ;
Xiao, Mengqing ;
Zhang, Yao ;
Gong, Lian ;
Xiao, Songshu ;
Cao, Ke .
FRONTIERS IN ONCOLOGY, 2021, 11
[4]   N6-methyladenosine Steers RNA Metabolism and Regulation in Cancer [J].
Dong, Shenghua ;
Wu, Yutong ;
Liu, Yadi ;
Weng, Hengyou ;
Huang, Huilin .
CANCER COMMUNICATIONS, 2021, 41 (07) :538-559
[5]   Pyroptosis: A new frontier in cancer [J].
Fang, Yuan ;
Tian, Shengwang ;
Pan, Yutian ;
Li, Wei ;
Wang, Qiming ;
Tang, Yu ;
Yu, Tao ;
Wu, Xi ;
Shi, Yongkang ;
Ma, Pei ;
Shu, Yongqian .
BIOMEDICINE & PHARMACOTHERAPY, 2020, 121
[6]   Immune Infiltrates of m6A RNA Methylation-Related lncRNAs and Identification of PD-L1 in Patients With Primary Head and Neck Squamous Cell Carcinoma [J].
Feng, Zi-Yi ;
Gao, Hao-Yu ;
Feng, Tian-Da .
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
[7]   Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data [J].
Finotello, Francesca ;
Mayer, Clemens ;
Plattner, Christina ;
Laschober, Gerhard ;
Rieder, Dietmar ;
Hackl, Hubert ;
Krogsdam, Anne ;
Loncova, Zuzana ;
Posch, Wilfried ;
Wilflingseder, Doris ;
Sopper, Sieghart ;
Ijsselsteijn, Marieke ;
Brouwer, Thomas P. ;
Johnson, Douglas ;
Xu, Yaomin ;
Wang, Yu ;
Sanders, Melinda E. ;
Estrada, Monica V. ;
Ericsson-Gonzalez, Paula ;
Charoentong, Pornpimol ;
Balko, Justin ;
de Miranda, Noel Filipe da Cunha Carvahlo ;
Trajanoski, Zlatko .
GENOME MEDICINE, 2019, 11 (1)
[8]   m6A RNA methylation and beyond - The epigenetic machinery and potential treatment options [J].
Garbo, Sabrina ;
Zwergel, Clemens ;
Battistelli, Cecilia .
DRUG DISCOVERY TODAY, 2021, 26 (11) :2559-2574
[9]   pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels [J].
Geeleher, Paul ;
Cox, Nancy ;
Huang, R. Stephanie .
PLOS ONE, 2014, 9 (09)
[10]   Interactions between m6A modification and miRNAs in malignant tumors [J].
Han, Xiao ;
Guo, Jing ;
Fan, Zhipeng .
CELL DEATH & DISEASE, 2021, 12 (06)